Related Experiment Video

Updated: Oct 15, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.9K

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway

Yanlin Cai1, Yi Hu1, Furong Yu1

  • 1Department of Gynecology and Obstetrics, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Aging
|October 24, 2021
PubMed

Insights

AHNAK protein is downregulated in ovarian cancer. Restoring AHNAK levels inhibits ovarian cancer cell growth and metastasis, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer deaths with a poor prognosis.
  • Understanding ovarian cancer progression mechanisms and identifying new therapeutic targets are crucial.
  • The role of AHNAK (a desmosomal protein) in ovarian cancer is not well-established.

Purpose of the Study:

  • To investigate the expression levels of AHNAK in ovarian cancer.
  • To determine the functional role of AHNAK in ovarian cancer cell proliferation and metastasis.
  • To elucidate the molecular mechanisms by which AHNAK influences ovarian cancer progression.

Main Methods:

  • AHNAK expression was analyzed in ovarian cancer tissues and cell lines.
  • AHNAK was overexpressed in ovarian cancer cells in vitro and in vivo.
  • Cell proliferation, migration, and invasion assays were performed.
  • The effect of AHNAK on the Canonical Wnt signaling pathway was evaluated.

Main Results:

  • AHNAK expression was found to be significantly downregulated in ovarian cancer tissues and cell lines.
  • Overexpression of AHNAK suppressed ovarian cancer cell proliferation, migration, and invasion in vitro.
  • In vivo studies demonstrated that elevated AHNAK levels inhibited tumor growth and metastasis.
  • AHNAK was found to dampen the Canonical Wnt signaling pathway, a key pathway in cancer progression.

Conclusions:

  • AHNAK acts as a tumor suppressor in ovarian cancer.
  • Restoring AHNAK expression can inhibit ovarian cancer progression.
  • AHNAK may serve as a valuable biomarker and therapeutic target for ovarian cancer treatment.
Keywords:
AHNAKWnt/β-cateninmetastasisovarian cancerproliferation

More Related Videos

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

1.7K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.5K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
66.3K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
4.6K